3 ms·
> The only problem where I don’t yet see a clear path forward yet is how to develop more efficient ways to recruit patients for clinical trials. Without a simpl
by peteretep 8y ago
> The only problem where I don’t yet see a clear path forward yet is how to develop more efficient ways to recruit patients for clinical trials. Without a simple and reliable diagnostic for Alzheimer’s, it’s hard to find eligible people early enough in the disease’s progression who can participate in trials.
There’s an interesting use case for Facebook’s Machine Learning algorithms
- yulaow 8y agoOh please NO. Let's try to not insert facebook also in our supersensitive medical data, considering how shady they are even with non-sensitive data it's clear it won't end well at all.